One year in review 2020: fibromyalgia. (2020 study) Skip to main content
Review Clinical and experimental rheumatology 2020

One year in review 2020: fibromyalgia.

Bazzichi L, Giacomelli C, Consensi A, Giorgi V, Batticciotto A, Di Franco M, et al., Clinical and experimental rheumatology, 2020

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reviewed recent studies about fibromyalgia, a condition causing widespread pain and fatigue, published between January 2019 and January 2020.

What They Found

This is a narrative literature review, not a clinical trial, so it summarizes existing publications rather than reporting new data or statistics. It identifies a new concept called "nociplastic pain" as part of how fibromyalgia pain is understood, along with neuroendocrine and metabolic changes found in people with fibromyalgia. It notes that researchers have been investigating new uses for existing drugs, along with complementary therapies such as hyperbaric oxygen, ozone therapy, and mindfulness-based approaches, as topics of recent discussion in the literature. The abstract does not report outcomes, success rates, or specific numbers for any of these therapies.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

As a review article rather than original research, it reports what other studies discussed rather than independently testing any treatment, so it provides no direct evidence on whether any specific therapy works for fibromyalgia.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Neurological
Source Pubmed
PubMed ID 32116216
Year Published 2020
Journal Clinical and experimental rheumatology
MeSH Terms Chronic Pain; Complementary Therapies; Fatigue; Fibromyalgia; Humans; Quality of Life

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology